Modular, bioorthogonal strategy for the controlled loading of cargo into a protein nanocage

Autor: Margo van der Pijl, Kimberly M. Bonger, Roeland J. M. Nolte, Mark B. van Eldijk, Selma Eising, Jaleesa Bresseleers, Lise Schoonen, Jan C. M. van Hest
Přispěvatelé: Bio-Organic Chemistry
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Spectrometry
Mass
Electrospray Ionization

Proton Magnetic Resonance Spectroscopy
viruses
Protein domain
Biomedical Engineering
Pharmaceutical Science
Bioengineering
02 engineering and technology
010402 general chemistry
01 natural sciences
Bio-Organic Chemistry
Article
chemistry.chemical_compound
Capsid
Carbon-13 Magnetic Resonance Spectroscopy
GeneralLiterature_REFERENCE(e.g.
dictionaries
encyclopedias
glossaries)

Pharmacology
Cowpea chlorotic mottle virus
biology
Organic Chemistry
Proteins
Bio-Molecular Chemistry
021001 nanoscience & nanotechnology
biology.organism_classification
Bromovirus
0104 chemical sciences
Nanostructures
chemistry
Covalent bond
Cyclization
Drug delivery
Biophysics
Capsid Proteins
Electrophoresis
Polyacrylamide Gel

Azide
Bioorthogonal chemistry
Nanocarriers
0210 nano-technology
Physical Organic Chemistry
Biotechnology
Zdroj: Bioconjugate Chemistry
Bioconjugate Chemistry, 29, 4, pp. 1186-1193
Bioconjugate Chemistry, 29(4), 1186-1193. American Chemical Society
Bioconjugate Chemistry, 29, 1186-1193
ISSN: 1043-1802
1186-1193
Popis: Virus capsids, i.e., viruses devoid of their genetic material, are suitable nanocarriers for biomedical applications such as drug delivery and diagnostic imaging. For this purpose, the reliable encapsulation of cargo in such a protein nanocage is crucial, which can be accomplished by the covalent attachment of the compounds of interest to the protein domains positioned at the interior of the cage. This approach is particularly valid for the capsid proteins of the cowpea chlorotic mottle virus (CCMV), which have their N-termini located at the inside of the capsid structure. Here, we examined several site-selective modification methods for covalent attachment and encapsulation of cargo at the N-terminus of the CCMV protein. Initially, we explored approaches to introduce an N-terminal azide functionality, which would allow the subsequent bioorthogonal modification with a strained alkyne to attach the desired cargo. As these methods showed compatibility issues with the CCMV capsid proteins, a strategy based on 2-pyridinecarboxaldehydes for site-specific N-terminal protein modification was employed. This method allowed the successful modification of the proteins, and was applied for the introduction of a bioorthogonal vinylboronic acid moiety. In a subsequent reaction, the proteins could be modified further with a fluorophore using the tetrazine ligation. The application of capsid assembly conditions on the functionalized proteins led to successful particle formation, showing the potential of this covalent encapsulation strategy.
Databáze: OpenAIRE